http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013150716-A

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2013150716-A
titleOfInvention METHOD FOR PRODUCING (±) N- [1- (4-fluorophenyl) -2- (1-ethylpiperidin-4-yl) ethyl] -4-nitrobenzamide or its pharmaceutically acceptable salts and the intermediate compound for it
abstract 1. The method of obtaining (±) N- [1- (4-fluorophenyl) -2- (1-ethylpiperidin-4-yl) ethyl] -4-nitrobenzamide of the formula or its pharmaceutically acceptable salts, which consists in the fact that ethyl ester 4- fluorobenzoic acid is reacted with 4-picoline in tetrahydrofuran in the presence of a catalyst or a condensing agent to obtain 1- (4-fluorophenyl) -2- (4-pyridyl) ethanone, which is alkylated with ethyl halide and the resulting pyridinium salt is subjected to catalytic reduction with hydrogen in the presence of palladium or platinum catalyst with the addition of concentrated hydrochloric acid to obtain 2- (1-ethylpiperidin-4-yl) -1- (4-fluorophenyl) ethanone of the formula which is subjected to reductive amination to obtain [2- (1-ethylpiperidin-4-yl) -1- (4- fluorophenyl) ethyl] amine, followed by reaction of the latter with 4-nitrobenzoic acid chloride to give (±) N- [1- (4-fluorophenyl) -2- (1-ethylpiperidin-4-yl) ethyl] -4-nitrobenzamide of formula (I) in free form or in the form of a pharmaceutically acceptable salt thereof. 2. A method according to claim 1, characterized in that (±) N- [1- (4-fluorophenyl) -2- (1-ethylpiperidin-4-yl) ethyl] -4-nitrobenzamide hydrochloride of the formula (I) is obtained. The method according to claim 1, characterized in that as a condensing agent use sodium bis (trimethylsilyl) amide in an amount of 1-2 mol per mole of 4-fluorobenzoate. 2- (1-ethylpiperidin-4-yl) -1- (4-fluorophenyl) ethanone corresponding to formula (II) 5. The use of 2- (1-ethylpiperidin-4-yl) -1- (4-fluorophenyl) ethanone corresponding to formula (II) as an intermediate for the synthesis of (±) N-1 [- (4-fluorophenyl) -2- ( 1-ethyl-4-piperidyl) ethyl] -4-nitrobenzamide in free form or in the form of pharmaceutically acceptable salts.
priorityDate 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415738980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3014095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57331232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142765650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429465264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420010458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4989215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424613337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420012849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10330881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421961548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592

Total number of triples: 40.